PQ is a $1.2 billion global specialty chemical company generating EBITDA of $300 million. Led a joint S-1 registration project for potential IPO in concert with a formal strategic sale process throughout most of 2014.

Avantor is a global manufacturer and distributor of high-quality products, services and solutions to professionals in the life sciences and advanced technology industries.

$2.9B global manufacturer of polymer additives, fine chemicals and catalysts for a wide array of applications. Lead operations for entire global organization for all businesses reporting to the CEO. Responsible for the corporation’s merger, acquisition and corporate development activities, as well as all supply chain and logistics activities. Represent the company with financial analysts, investor conferences, major investors, and road shows for expansion of bond and equity positions.

Global sales and operational responsibility for all three Albemarle businesses, fine chemicals, polymers and catalysts. Built and expanded the specialty chemicals business with the integration of a major acquisition.

Operational responsibility for the company’s fine chemicals, catalysts and polymers businesses including R&D. Led the establishment of an S & OP process across the company for managing inventory and working capital.

Responsible for manufacturing, sales, purchasing, logistics and R&D for $400M specialty chemicals business. Dramatically restructured new product development and integrated game changing acquisition for the business model.

Profit and loss responsibility for the company’s specialty chemicals business. Achieved record earnings in 1997 for PAP/APAP with results 25% over budget. Drove financial turnaround for the specialty chemicals business. Exceeded projected earnings in 1998 to $8M over budget of $20M, resulting in 44% profit increase.